Peripheral neuropathy decisions — 2025

The Board remands the claims for service connection for peripheral neuropathy of both upper and lower extremities, to include as due to herbicide agent exposure, for compliance with a Court order regarding the provision of an examiner's curriculum vitae.

The Board denied the claim for service connection for bilateral pes planus, finding that it preexisted service and did not increase in disability. The claims for ischemic heart disease, diabetes mellitus, peripheral neuropathy, hypertension, and pes planus were remanded for further development.

The Board denied service connection for diabetes mellitus type II and bilateral lower extremity neuropathy, finding that the evidence did not support a causal relationship between these conditions and the Veteran's active military service.

The Board denied service connection for peripheral neuropathy in the left and right upper extremities as there is no evidence of a current diagnosis.

The veteran withdrew his appeals for service connection for degenerative arthritis of the spine, bilateral neuropathy below the hips, and a skin disability.

The Board denied service connection for left shoulder rotator cuff tendonitis with AC osteoarthritis and remanded the claims for bilateral hand condition, right upper extremity peripheral neuropathy, and erectile dysfunction.

The Board denied service connection for various conditions, including GERD, bilateral vision impairment, chronic kidney disease, diabetes mellitus, erectile dysfunction, headaches, heart disability, hypertension, left upper extremity neuropathy, right upper extremity neuropathy, an acquired psychiatric disorder, a right hip condition, sleep apnea, and urinary frequency.

The Board denied service connection for various conditions and a higher disability rating for PTSD, as the evidence did not support the presence of current disabilities or a nexus to service.

The Board granted increased ratings for right and left upper extremity neuropathy, right and left lower extremity diabetic peripheral neuropathy, and hypothyroidism, as well as a TDIU from May 1, 2018 to September 19, 2019. The Board denied increased ratings for diabetes mellitus, type II, kidney disease stage III with hypertension (kidney disease with hypertension), tinnitus, and service connection for migraines.

The Board granted service connection for a right hip disability, back disability, and bilateral lower extremity neuropathy but denied the claim for bilateral plantar fasciitis.

The Board granted a TDIU and an effective date of October 22, 2023, for the award of a 20 percent evaluation for right and left lower extremity diabetic peripheral neuropathy.

The veteran withdrew his appeal seeking increased ratings for various conditions, including peripheral neuropathy and non-alcoholic steatohepatitis.

The Board granted initial ratings of 70 percent for right upper extremity peripheral neuropathy, 60 percent for left upper extremity peripheral neuropathy, and 30 percent each for right and left lower extremity peripheral neuropathy (femoral and sciatic nerves), while denying an increased rating for allergic rhinitis and granting a 10 percent rating for chloracne of the face, arms, and back prior to September 27, 2018.

The Board granted service connection for neuropathy in both the right and left lower extremities, based on in-service herbicide agent exposure during the Vietnam War.

The Veteran is granted special monthly compensation (SMC) based on the loss of use of both feet due to his service-connected bilateral lower extremity disabilities.

The Board denied higher ratings for the service-connected peripheral neuropathy of the upper and lower extremities both prior to and from May 25, 1999.

The Board denied service connection for a left shoulder disorder, right shoulder disorder, back disorder, and neuropathy as the evidence did not support a finding that these conditions were related to the Veteran's military service.

The Board remands the claims for service connection for prostate cancer, diabetes mellitus type II, and diabetic neuropathy of the upper and lower extremities due to a need for clarification regarding the Veteran's exposure to Agent Orange.

The Board denied service connection for chronic fatigue syndrome (CFS) and remanded claims for a disability manifested by shortness of breath, hypertension, diabetes mellitus, type II, and left lower neuropathy.

The Board granted service connection for lumbosacral spondylosis with degenerative disc disease and bilateral lower extremity lumbar radiculopathy, finding a nexus to the Veteran's military service.